Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Corey

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsG Ralph Corey, Jamie A McKinnell, Michael J Rybak
Expert Opinion on Pharmacotherapy|March 25, 2015
Oritavancin for acute bacterial skin and skin structure infectionsJulia A Messina, Vance G Fowler, G Ralph Corey
Expert Opinion on Pharmacotherapy|April 21, 2010
Ceftaroline for complicated skin and skin-structure infectionsEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Expert Review of Anti-Infective Therapy|October 4, 2012
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studiesEsteban C Nannini, G Ralph Corey, Martin E Stryjewski
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsG Ralph Corey, Jamie A McKinnell, Michael J Rybak
Expert Opinion on Pharmacotherapy|March 25, 2015
Oritavancin for acute bacterial skin and skin structure infectionsJulia A Messina, Vance G Fowler, G Ralph Corey
Expert Opinion on Pharmacotherapy|April 21, 2010
Ceftaroline for complicated skin and skin-structure infectionsEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Expert Review of Anti-Infective Therapy|October 4, 2012
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studiesEsteban C Nannini, G Ralph Corey, Martin E Stryjewski
Pageof 18